Pharma Journalist 8969 posts 0 comments

BeOne Medicines has announced a $300 million investment to expand its flagship manufacturing and research facility in Hopewell, New Jersey, strengthening its U.S. production…
Read More...

Kairos Pharma has announced a strategic collaboration with Bayer to evaluate a new combination treatment approach for metastatic castration-resistant prostate cancer (mCRPC) that has…
Read More...

Cellares and Papillon Therapeutics have announced a strategic collaboration to automate the manufacturing of PPL-001, an investigational gene-edited cell therapy being developed to…
Read More...

GSK has received U.S. Food and Drug Administration (FDA) approval for Jideytro (zidesamtinib), a next-generation targeted therapy for adults with locally advanced or metastatic…
Read More...

Crystalys Therapeutics has secured $130 million in an oversubscribed Series B financing round to support the late-stage clinical development and commercialization of its lead gout…
Read More...

Evogene Ltd. and South Korea-based biotechnology company ELEO Inc. have entered into a strategic scientific collaboration to develop next-generation oral small-molecule therapies…
Read More...

Lonza and Engitix have entered into a licensing agreement aimed at accelerating the development of next-generation antibody-drug conjugates (ADCs), combining Lonza’s established drug…
Read More...

Samsung Biologics has announced an agreement to acquire Swiss contract development and manufacturing organization (CDMO) PolyPeptide Group AG in an all-cash transaction valued at…
Read More...

Halozyme Therapeutics and Incyte have entered into a global collaboration and licensing agreement to develop additional subcutaneous formulations of Incyte's investigational blood…
Read More...

Bristol Myers Squibb (BMS) is significantly expanding its artificial intelligence capabilities with the deployment of a second NVIDIA DGX SuperPOD, strengthening its efforts to…
Read More...